KING OF PRUSSIA, Pa. -- (BUSINESS WIRE) -- The first Theorem Think Tank on drug development will be held in Boston from 3-7 p.m., March 7. Led by noted leaders in their respective fields, the six sessions offer insight into key aspects of the drug and medical device development process for groups and individuals seeking a better understanding. There is no cost to attend.
“This is a fabulous opportunity for people working in pharmaceutical companies, academia or research organizations to gain a broader perspective on the whole pharmaceutical and medical device development continuum,” said Dr. John Potthoff, Theorem Clinical Research president and CEO.
Sessions are divided into two tracks, enabling participants to choose among the topics.
The Theorem Think Tank will be held at the Boston Marriott Cambridge, 50 Broadway, Cambridge, Mass. Registration is free, but must be completed in advance.
“If you’re involved in the drug development industry, this is a rare opportunity to gain important insights from some of the real leaders in contract research,” Potthoff said. “Take us up on this chance to ask the questions you’ve always wanted to ask, talk one-on-one with leading experts and get valuable advice on your own development programs.”
About Theorem Clinical Research
Theorem Clinical Research Inc. is a leading midsized provider of comprehensive clinical research and development services with offices in more than 30 countries and a customer base comprised of some of the world's leading pharmaceutical, biotech and medical device companies. A leader in medical device and drug-device combination trials in addition to a notable capability in pharmaceuticals and biologics, Theorem has deep expertise in a broad range of therapeutic areas and in all phases of development. Some of the industry's top scientists and most advanced clinical analytics capabilities help ensure smooth-running, successful trials. For a full-service, right-size global research partner, don't think twice. THINK THEOREM.